CD117 Positive Cells Significantly Exist in Immune-targeted Follicles of Alopecia Areata

Keroles N. Gendy

Department of Dermatology and Venereology, Faculty of Medicine, Minia University, Egypt.

Amal T. Abdel-Rahman

Department of Dermatology and Venereology, Faculty of Medicine, Minia University, Egypt.

Manal Y. Gabril

Department of Pathology and Laboratory Medicine, Western University, Ontario, Canada.

Sherif S. Awad *

Department of Dermatology and Venereology, Faculty of Medicine, Minia University, Egypt.

*Author to whom correspondence should be addressed.


Aim: Studying the expression of CD117 (c-kit) in hair follicles of Alopecia Areata (AA).

Place and Duration of Study: Department of dermatology and venereology, Minia university hospital, Egypt and Department of Pathology and laboratory medicine, Western University, Ontario, Canada, between July 2022 and July 2023.

Methodology: This study included 16 AA patients, Skin biopsies were obtained from each participant and stained with hematoxylin and eosin (H&E) and CD117 immune stain, all hair follicles are numbered and evaluated for presence of infiltrates and expression of CD117. Correlation was done between existence of perifollicular inflammatory infiltrate and expression of CD117 in all hair follicles in cross section.

Results: Within 82 follicles examined, CD117 was significantly expressed in immune targeted follicles. The median of positive expression was 2 with interquartile range (IQR) (1-3), the expression decreased in non-infiltrated follicles the median was 1 with IQR (0-1.8) with statistically significant difference (P = 0.001).

Conclusion: CD117 is significantly expressed in hair follicles of AA and is correlated to the immune cytotoxic infiltrates and possibly to the pathogenesis of alopecia areata.

Keywords: CD117, alopecia areata, hair follicle-immunohistochemistry

How to Cite

Gendy, K. N., Abdel-Rahman, A. T., Gabril, M. Y., & Awad, S. S. (2023). CD117 Positive Cells Significantly Exist in Immune-targeted Follicles of Alopecia Areata. Asian Journal of Research in Dermatological Science, 6(1), 82–89. Retrieved from


Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: A review of disease pathogenesis. Br J Dermatol. 2018;179(5): 1033-1048. DOI: 10.1111/bjd.16808

Cruse G, Metcalfe DD, Olivera A. Functional deregulation of kit: Link to mast cell proliferative diseases and other neoplasms. Immunol Allergy Clin North Am. 2014;34(2):219-237. DOI: 10.1016/j.iac.2014.01.002

Galanis A, Levis M. Inhibition of c-Kit by tyrosine kinase inhibitors. Haematologica. 2015;100(3):e77-e79.

DOI: 10.3324/haematol.2014.117028

Kemp EH, Sandhu HK, Weetman AP, McDonagh AJ. Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata. Br J Dermatol. 2011;165(6): 1236-1243.

DOI: 10.1111/j.1365-2133.2011.10597.x

Yousaf A, Lee J, Fang W, Kolodney MS. Notice of retraction. Yousaf A, et al. Association between alopecia areata and natural hair color among white individuals. JAMA Dermatol.2021;157(8):1007-1008.

DOI: 10.1001/jamadermatol.2021.1832

Headington JT. Transverse microscopic anatomy of the human scalp. A basis for a morphometric approach to disorders of the hair follicle. Arch Dermatol. 1984;120(4): 449-456.

Trautman S, Thompson M, Roberts J, Thompson CT. Melanocytes: A possible autoimmune target in alopecia areata. J Am Acad Dermatol. 2009;61(3):529-530. DOI: 10.1016/j.jaad.2009.01.017

Zhou C, Li X, Wang C, Zhang J. Alopecia areata: An update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021;61(3):403-423. DOI: 10.1007/s12016-021-08883-0

Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: A multifactorial autoimmune condition. J Autoimmun. 2019;98:74-85. DOI: 10.1016/j.jaut.2018.12.001

Paus R, Bulfone-Paus S, Bertolini M. Hair follicle immune privilege revisited: The key to alopecia areata management. J Investig Dermatol Symp Proc. 2018;19(1):S12-S17. DOI: 10.1016/j.jisp.2017.10.014

Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest. 1998;101(1):62-67.

DOI: 10.1172/JCI551

Xing L, Dai Z, Jabbari A, et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20(9):1043-1049. DOI: 10.1038/nm.3645

Xie B, Sun J, Song X. Hair follicle melanocytes initiate autoimmunity in alopecia areata: A trigger point. Clin Rev Allergy Immunol. 2022; 63 (3):417-430. DOI: 10.1007/s12016-022-08954-w

Jia WX, Mao QX, Xiao XM, Li ZL, Yu RX, Li CR. Patchy alopecia areata sparing gray hairs: A case series. Postepy Dermatol Alergol. 2014;31 (2):113-116. DOI: 10.5114/pdia.2014.40956

Paus R. The evolving pathogenesis of alopecia areata: Major open questions. J Investig Dermatol Symp Proc. 2020;20 (1):S6-S10. DOI: 10.1016/j.jisp.2020.04.002

Tobin DJ, Bystryn JC. Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res. 1996;9(6):304-310. DOI: 10.1111/j.1600-0749.1996.tb00122.x

Simon JD, Hong L, Peles DN. Insights into melanosomes and melanin from some interesting spatial and temporal properties. J Phys Chem B. 2008;112(42):13201-13217. DOI: 10.1021/jp804248h

Leung MC, Sutton CW, Fenton DA, Tobin DJ. Trichohyalin is a potential major autoantigen in human alopecia areata. J Proteome Res. 2010;9(10):5153-5163. DOI: 10.1021/pr100422u

Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1-12. DOI: 10.1016/j.jaad.2017.04.1141

Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R. Hair follicle immune privilege and its collapse in alopecia areata. Exp Dermatol. 2020;29(8): 703-725. DOI: 10.1111/exd.14155

Mourad B, Hasby, E, Elfar N. Immunohistochemical study assessing stem cell factor receptor C-kit in patients with alopecia. Egyptian Journal of Dermatology and Venereology. 2020;40(2):84.

Mohanan S, Sylvia MT, Carounanidy U, Bhat RV. Expression of CD117 and platelet-derived growth factor receptor α in patients with alopecia areata. Indian J Dermatol Venereol Leprol. 2020;86(6):643-648.

DOI: 10.4103/ijdvl.IJDVL_557_19

Ashrafuzzaman M, Yamamoto T, Shibata N, Hirayama TT, Kobayashi M. Potential involvement of the stem cell factor receptor c-kit in alopecia areata and androgenetic alopecia: Histopathological, immunohistochemical, and semiquantitative investigations. Acta Histochem Cytochem. 2010;43(1):9-17.